Dachaigh › Lymphoma Cealla B Mòr Sgaoilte › North Carolina › Durham
Sgrùdaidhean clionaigeach Lymphoma Cealla B Mòr Sgaoilte ann an Durham, NC
Tha 14 sgrùdaidhean airson Lymphoma Cealla B Mòr Sgaoilte a’ lorg phàirtichean aig làraichean ann agus timcheall air Durham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A’ fastadhÌre 2
- Duke Blood Cancer Center, Durham
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A’ fastadhÌre 2
- University of North Carolina Medical Center ( Site 0136), Chapel Hill · 10 mìle air falbh
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
A’ fastadhÌre 3
- Duke University Medical Center, Durham
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A’ fastadhÌre 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mìle air falbh
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
A’ fastadhSgrùdadh amharc
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A’ fastadhÌre 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
A’ fastadhÌre 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
- Duke University Medical Center, Durham
Registry of Older Patients With Cancer
A’ fastadhSgrùdadh amharc
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mìle air falbh
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
A’ fastadhÌre 1
- Duke Univerisity, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
A’ fastadhSgrùdadh amharc
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mìle air falbh
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
A’ fastadhÌre 1
- University of North Carolina, Chapel Hill · 10 mìle air falbh
A Study of NX-1607 in Adults With Advanced Malignancies
A’ fastadhÌre 1
- University of North Carolina, Chapel Hill · 10 mìle air falbh
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
A’ fastadhÌre 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Sgrùdaidhean Lymphoma Cealla B Mòr Sgaoilte ann am bailtean eile
- New York City, NY21 sgrùdaidhean
- Baldwin Park, CA19 sgrùdaidhean
- Chicago, IL18 sgrùdaidhean
- Houston, TX17 sgrùdaidhean
- Los Angeles, CA17 sgrùdaidhean
- Milwaukee, WI16 sgrùdaidhean
- Boston, MA16 sgrùdaidhean
- Nashville, TN15 sgrùdaidhean
- Philadelphia, PA15 sgrùdaidhean
- Portland, OR15 sgrùdaidhean
- Dallas, TX13 sgrùdaidhean
- Washington, DC12 sgrùdaidhean
Sgrùdaidhean eile ann an Durham
- Aillse a' bhroilleach64 sgrùdaidhean
- Aillse (gach seòrsa)58 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag39 sgrùdaidhean
- Myeloma iomaill37 sgrùdaidhean
- Leukemia myeloid geur33 sgrùdaidhean
- Ailse metastatach33 sgrùdaidhean
- Aillse Prostata32 sgrùdaidhean
- Ailseachadh nan Sgamhan32 sgrùdaidhean
- Aillse colorectal28 sgrùdaidhean
- Cancer Ovarian27 sgrùdaidhean
- Leukemia Lymphocytic Cronach27 sgrùdaidhean
- Fàilligeadh a' Chridhe26 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.